e-learning
resources
Stockholm 2007
Wednesday 19.09.2007
Lung function and therapy in obstructive lung diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Study of PFT‘s in patients with type 2 diabetes mellitus and diabetic neuropathy and microangiopathy
C. Belias, A. Pentheroudaki, G. Meletis, M. Chistodoulou, M. Ferdoutsis, G. Patsourakis, E. Thanou, C. Pigakis, E. Kirlaki, N. Kefalogiannis, N. Bachlitzanakis (Heraklion, Crete, Greece)
Source:
Annual Congress 2007 - Lung function and therapy in obstructive lung diseases
Session:
Lung function and therapy in obstructive lung diseases
Session type:
Electronic Poster Discussion
Number:
4379
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Belias, A. Pentheroudaki, G. Meletis, M. Chistodoulou, M. Ferdoutsis, G. Patsourakis, E. Thanou, C. Pigakis, E. Kirlaki, N. Kefalogiannis, N. Bachlitzanakis (Heraklion, Crete, Greece). Study of PFT‘s in patients with type 2 diabetes mellitus and diabetic neuropathy and microangiopathy. Eur Respir J 2007; 30: Suppl. 51, 4379
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Occupational exposure and obstructive lung diseases: what we can learn from the large-scale European studies
COPD prediction by using imaging and genetic profiles
COPD heterogeneity and sub-phenotypes
Related content which might interest you:
Control of ventilation in patients with insulin-dependent diabetes mellitus complicated by autonomic neuropathy
Source: Eur Respir J 2005; 26: Suppl. 49, 66s
Year: 2005
Pulmonary microangiopathy as a possible complication in patients with diabetes mellitus
Source: Eur Respir J 2004; 24: Suppl. 48, 222s
Year: 2004
A study of the comorbidity of COPD and type 2 diabetes mellitus
Source: International Congress 2018 – COPD and extrapulmonary comorbidities
Year: 2018
The conjunctival microcirculation disturbances at COPD patients in combination with diabetes mellitus type 2 and their correction by gliclazide
Source: Eur Respir J 2004; 24: Suppl. 48, 61s
Year: 2004
Comparison of COPD patients with and without diabetes mellitus
Source: Virtual Congress 2020 – Diagnosis and management of COPD
Year: 2020
Role of BMI in the clinical course of COPD patients with type 2 diabetes mellitus
Source: International Congress 2018 – COPD and extrapulmonary comorbidities
Year: 2018
Presence of diabetic autonomic neuropathy in children with type 1 diabetes mellitus is associated with the significant decrease of cough reflex sensitivity
Source: Annual Congress 2007 - Current issues in airway physiology, pharmacology and monitoring
Year: 2007
COPD prevalence and severity is associated to type 2 diabetes mellitus complications and lack of glycometabolic control
Source: Annual Congress 2008 - COPD and comorbidities
Year: 2008
Metformin predispose acute exacerbations of COPD patients with insulin-dependent diabetes mellitus>
Source: International Congress 2018 – COPD and extrapulmonary comorbidities
Year: 2018
Respiratory muscle function in type 2 diabetes mellitus
Source: Annual Congress 2008 - Assessment of the respiratory system
Year: 2008
Screening for diabetes mellitus in patients with OSAS: a case for glycosylated haemoglobin
Source: Eur Respir J 2012; 40: 273-274
Year: 2012
Study of pulmonary function in type2 diabetes mellitus and its changes with change in duration and glycemic control
Source: Annual Congress 2012 - Pathophysiological mechanisms in disease: new insights
Year: 2012
Relative risk of type 2 diabetes mellitus complications is increased in non effectively treated OSA patients
Source: Eur Respir J 2005; 26: Suppl. 49, 39s
Year: 2005
Type 2 diabetes mellitus risk associated with sarcoidosis: A Swedish population-based cohort study
Source: Virtual Congress 2020 – Sarcoidosis: from genetics to epidemiology
Year: 2020
Is there any characteristics difference between pulmonary tuberculosis patients with and without diabetes mellitus type 2?
Source: Annual Congress 2009 - Tuberculosis: metabolism and comorbidities
Year: 2009
The association of pulmonary fibrosis with diabetes mellitus
Source: ERJ Open Res, 6 (4) 00237-2020; 10.1183/23120541.00237-2020
Year: 2020
Presentations and treatment response of pulmonary tuberculosis in type 2 diabetes mellitus
Source: Annual Congress 2012 - Tuberculosis: clinical findings II
Year: 2012
Development of diabetes mellitus in patients with bronchial asthma
Source: Annual Congress 2008 - Novel experimental approaches to understanding asthma and COPD II
Year: 2008
Familial co-aggregation of asthma and type 1 diabetes mellitus in children– a Swedish population-based cohort study
Source: Virtual Congress 2020 – Novel mechanisms and management of paediatric asthma
Year: 2020
Clinical features of pulmonary tuberculosis in patients with diabetes mellitus
Source: Annual Congress 2012 - Tuberculosis: clinical findings III
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept